Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 3.16 CHF -3.66% Market Closed
Market Cap: 127.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 10.71 CHF with a low forecast of 6.06 CHF and a high forecast of 15.75 CHF.

Lowest
Price Target
6.06 CHF
92% Upside
Average
Price Target
10.71 CHF
239% Upside
Highest
Price Target
15.75 CHF
398% Upside
Molecular Partners AG Competitors:
Price Targets
MCRB
Seres Therapeutics Inc
954% Upside
300685
Amoy Diagnostics Co Ltd
54% Upside
BAVA
Bavarian Nordic A/S
85% Upside
6955
Shandong Boan Biotechnology Co Ltd
24% Downside
IMTX
Immatics NV
281% Upside
SLNO
Soleno Therapeutics Inc
41% Upside
688363
Bloomage Biotechnology Corp Ltd
12% Upside
TRDA
Entrada Therapeutics Inc
205% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -17%. The projected CAGR for the next 3 years is 151%.

-17%
Past Growth
151%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
10.71 CHF

According to Wall Street analysts, the average 1-year price target for MOLN is 10.71 CHF with a low forecast of 6.06 CHF and a high forecast of 15.75 CHF.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
151%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -17%. The projected CAGR for the next 3 years is 151%.

Back to Top